NHS Scotland, AZ and Scottish universities partner for kidney health research
The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland
Read More
Tag: chronic kidney disease
SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland
The serious, progressive kidney disease affects nearly 850 million people worldwide
Read More
Researchers suggest treatments for rare diseases could reduce burden of kidney disease
Rare kidney diseases are a group of conditions which account for over 5% of people living with chronic kidney disease
Read More
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
Chronic kidney disease affects roughly 700 million patients worldwide
Read More
Positive results for GSK’s anaemia drug daprodustat
Daprodustat is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development for anaemia due to chronic kidney disease
Read More
NICE issues draft recommendation for new kidney disease treatment
Forxiga becomes the first new treatment option for CKD patients in nearly 20 years
Read More
Cara, Vifor receive FDA nod for pruritus treatment
Korsuva injection will treat CKD patients undergoing haemodialysis
Read More
US rejects AZ and FibroGen’s anaemia drug roxadustat
FDA has requested an additional clinical trial on the safety of roxadustat
Read More
AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease
Approval based on DAPA-CKD Phase III data
Read More
Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients
The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study
Read More
AZ’s Farxiga scores US approval in chronic kidney disease
SGLT2 inhibitor approved for high-risk patients with and without type 2 diabetes
Read More
AZ presents new real-world chronic kidney disease data at ASN 2020
Initial key findings from the DISCOVER-Chronic Kidney Disease study revealed
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
